Viewing Study NCT03054506



Ignite Creation Date: 2024-05-06 @ 9:43 AM
Last Modification Date: 2024-10-26 @ 12:18 PM
Study NCT ID: NCT03054506
Status: COMPLETED
Last Update Posted: 2019-08-20
First Post: 2017-02-07

Brief Title: The Effect of CSP01 on Chronic Idiopathic Constipation and Irritable Bowel Syndrome With Constipation
Sponsor: Massachusetts General Hospital
Organization: Massachusetts General Hospital

Study Overview

Official Title: A Randomized Single Center Double-blind Parallel-group Placebo-controlled Study Assessing the Effect of CSP01 on Chronic Idiopathic Constipation and Irritable Bowel Syndrome With Constipation
Status: COMPLETED
Status Verified Date: 2019-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Constipation is a common gastrointestinal motility disorder that is often chronic negatively affects patients daily lives Constipation occurs when bowel movements become difficult or less frequentThis study is being done to study the effectiveness of the hydrogel capsule CSP01 compared to the active control carboxymethylcellulose and placebo non-medicine sugar pill to relieve constipation among subjects with chronic idiopathic constipation CIC or with irritable bowel syndrome with constipation IBS-C
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: True
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None